About Us

Gateway for Cancer Research has been harnessing the passion and drive of a global community of brilliant physicians, benevolent philanthropists and brave patients to advance transformational, early stage clinical trials for all types of cancer. This includes rare cancers for which funding is scarce as well as some of the most prevalent cancers affecting men, women and children today. Gateway exclusively funds Phase I and II research trials, which often mark the first-in-human studies of promising new cancer drugs, devices and therapies. As such, they represent a critical first step in evaluating new cancer treatments that help patients live longer and feel better while working to end cancer as we know it.